GENE ONLINE|News &
Opinion
Blog

Pain
Myovant, Pfizer’s Endometriosis Pain Treatment Gets FDA Greenlight
2022-08-08
Finland’s Orion Strikes for Jemincare’s Non-Opioid Painkiller, Paying $15 Million Upfront
2022-05-09
Marijuana for Medical Use Increases the Risk of Cannabis Use Disorder
2022-03-25
CRISPR-Based Analgesics Aspire to Mitigate Opioid Crisis
2021-03-16
Peptide Therapeutics Market: Promise for a Painless Future
2020-03-18
Relief for Patients as Baudax Bio’s Non-Opioid Analgesic Wins FDA Approval
2020-02-23
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
Dividend Exchange Rate for Q3 2025 Announced by DEC on March 12, 2026
2026-03-12
NewHydrogen Files International Patent Application for ThermoLoop Technology to Enhance Hydrogen Production Efficiency
2026-03-12
BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director
2026-03-12
Scroll to Top